Aurora annual revenue was C$247.94 m in FY 2019

Aurora Gross profit (Q2, 2020)29.9 M

Aurora Gross profit margin (Q2, 2020), %53.4%

Aurora Net income (Q2, 2020)-1.3 B

Aurora EBIT (Q2, 2020)-119.6 M

Aurora Cash, 31-Dec-2019156.3 M

Aurora revenue was C$247.94 m in FY, 2019 which is a 349.2% year over year increase from the previous period.

Aurora revenue breakdown by business segment: 13.9% from Medical (Cannabis Extracts), 35.7% from Consumer (Dried Cannabis), 9.1% from Auxiliary (Support Functions), 8.9% from Auxiliary (Wholesale Bulk), 29.1% from Medical (Dried Cannabis) and 3.2% from Other

CAD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Revenue | 18.1m | 55.2m | 247.9m |

| 206% | 349% | |

## Cost of goods sold | 2.0m | 11.7m | 88.1m |

## Gross profit | 16.1m | 43.5m | 159.8m |

| 89% | 79% | 64% |

## Sales and marketing expense | 10.3m | 29.4m | 99.3m |

## R&D expense | 314.0k | 1.7m | 14.8m |

## General and administrative expense | 6.8m | 43.0m | 172.4m |

## Operating expense total | 27.2m | 139.3m | 474.1m |

## Depreciation and amortization | 716.0k | 12.1m | 63.4m |

## EBIT | (11.2m) | (95.8m) | (314.2m) |

| (62%) | (174%) | (127%) |

## Pre tax profit | (17.3m) | 77.3m | (328.2m) |

## Income tax expense | (4.3m) | 8.1m | (30.3m) |

## Net Income | (13.0m) | 69.2m | (297.9m) |

CAD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|

## Revenue | 8.2m | 11.7m | 16.1m | 29.7m | 54.2m | 65.1m | 75.2m | 56.0m |

## Cost of goods sold | 5.2m | 8.5m | 21.6m | 22.0m | 12.5m | 21.5m | 26.1m | |

## Gross profit | 6.5m | 7.6m | 8.1m | 32.1m | 52.6m | 53.7m | 29.9m | |

| 55% | 47% | 27% | 59% | 81% | 71% | 53% | |

## Sales and marketing expense | 3.7m | 5.1m | 5.9m | 29.4m | 22.7m | 16.3m | 22.0m | 29.1m |

## R&D expense | 107.0k | 172.0k | 477.0k | 3.4m | 1.8m | 3.5m | 6.0m | 6.8m |

## General and administrative expense | 3.0m | 7.6m | 9.8m | 35.9m | 43.6m | 50.8m | 59.1m | 70.8m |

## Operating expense total | 10.2m | 22.6m | 39.4m | 119.9m | 112.3m | 130.2m | 131.1m | 149.5m |

## Depreciation and amortization | 634.0k | 460.0k | 873.0k | 15.1m | 19.3m | 18.2m | 18.2m | 20.8m |

## EBIT | (1.4m) | (16.1m) | (31.8m) | (111.9m) | (80.2m) | (77.6m) | (77.4m) | (119.6m) |

| (17%) | (138%) | (197%) | (377%) | (148%) | (119%) | (103%) | (213%) |

## Pre tax profit | 4.7m | 10.0m | (22.0m) | 108.7m | (280.0m) | (169.1m) | 29.6m | (1.3b) |

## Income tax expense | 1.1m | 2.8m | (1.2m) | 4.5m | (40.3m) | (8.9m) | 19.2m | (24.3m) |

## Net Income | 3.6m | 7.2m | (20.8m) | 104.2m | (239.6m) | (160.2m) | 10.4m | (1.3b) |

CAD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Cash | 159.8m | 89.2m | 172.7m |

## Accounts Receivable | 1.3m | 6.7m | 85.2m |

## Prepaid Expenses | 1.5m | 7.6m | 24.3m |

## Inventories | 7.7m | 29.6m | 113.6m |

## Current Assets | 193.6m | 215.3m | 664.2m |

## PP&E | 45.5m | 246.4m | 765.6m |

## Goodwill | 41.1m | 729.1m | 3.2b |

## Total Assets | 322.7m | 1.9b | 5.5b |

## Accounts Payable | 38.7m | ||

## Short-term debt | 69.0k | 2.5m | 13.8m |

## Current Liabilities | 23.5m | 75.2m | 436.4m |

## Long-term debt | 282.0k | 9.2m | 127.5m |

## Total Debt | 351.0k | 11.7m | 141.2m |

## Total Liabilities | 103.7m | 347.6m | 1.1b |

## Common Stock | 221.4m | 1.5b | 4.7b |

## Retained Earnings | (28.4m) | 87.7m | (283.6m) |

## Total Equity | 322.7m | 1.6b | 4.4b |

## EPS | 0.0 | 0.2 | (0.3) |

## Debt to Equity Ratio | 0 x | 0 x | 0 x |

## Debt to Assets Ratio | 0 x | 0 x | 0 x |

## Financial Leverage | 1 x | 1.2 x | 1.3 x |

CAD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Net Income | (13.0m) | 69.2m | (297.9m) |

## Depreciation and Amortization | 1.1m | 12.3m | 88.3m |

## Accounts Receivable | (654.0k) | (5.9m) | (57.2m) |

## Inventories | (1.7m) | (10.4m) | (9.8m) |

## Accounts Payable | 2.6m | 3.1m | 103.1m |

## Cash From Operating Activities | (10.5m) | (81.7m) | (192.2m) |

## Purchases of PP&E | (25.7m) | (136.9m) | (414.3m) |

## Cash From Investing Activities | (50.5m) | (537.8m) | (312.3m) |

## Short-term Borrowings | (6.2m) | (281.0k) | (238.0k) |

## Long-term Borrowings | (4.2m) | (21.1m) | |

## Cash From Financing Activities | 220.3m | 548.5m | 597.5m |

## Net Change in Cash | 159.5m | (70.5m) | 95.9m |

CAD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|

## Net Income | 3.6m | 11.3m | (19.2m) | 104.2m | (135.5m) | (295.7m) | 10.4m | (1.3b) |

## Depreciation and Amortization | 776.0k | 1.5m | 1.2m | 16.0m | 42.0m | 71.4m | 29.7m | 61.3m |

## Accounts Receivable | 224.0k | 46.0k | (2.1m) | 2.2m | (8.3m) | (26.1m) | 8.8m | 21.5m |

## Inventories | (1.2m) | (2.7m) | (2.6m) | (19.3m) | (8.6m) | (6.0m) | (13.6m) | (42.7m) |

## Accounts Payable | (829.0k) | 3.4m | (13.1m) | 22.7m | 27.4m | 22.4m | (7.2m) | (38.3m) |

## Cash From Operating Activities | (5.0m) | (9.6m) | (26.9m) | (69.1m) | (133.0m) | (187.6m) | (94.9m) | (229.6m) |

## Purchases of PP&E | (21.1m) | (53.9m) | (43.7m) | (72.1m) | (150.1m) | (246.8m) | (108.7m) | (237.1m) |

## Cash From Investing Activities | (28.4m) | (108.4m) | (323.8m) | 23.3m | 179.4m | (136.1m) | (29.5m) | (161.1m) |

## Short-term Borrowings | (252.0k) | (2.3m) | (2.2m) | (175.0k) | ||||

## Long-term Borrowings | (9.0m) | (9.1m) | (19.1m) | (4.8m) | (10.2m) | |||

## Cash From Financing Activities | 1.3m | 309.3m | 230.9m | 105.4m | 179.4m | 627.7m | 103.8m | 375.1m |

## Net Change in Cash | (31.9m) | 191.0m | (119.8m) | 58.6m | (992.0k) | 301.0m | (20.2m) | (16.4m) |

CAD | Y, 2019 |
---|---|

## Debt/Equity | 0.1 x |

## Debt/Assets | 0.1 x |

## Financial Leverage | 1.2 x |

FY, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | FY, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | FY, 2019 | Q1, 2020 | Q2, 2020 | Feb, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Average Selling Price per Gram (Dried Cannabis) | C$6 | C$7 | C$7 | C$7 | C$8 | C$8 | C$6 | C$5 | C$4 | C$4 | C$4 | |

## Average Selling Price per Gram (Cannabis Extracts) | C$17 | C$16 | C$13 | C$12 | C$13 | C$12 | C$10 | C$11 | C$10 | C$11 | C$9 | |

## Active Registered Patients | 16.40 k | 19.28 k | 21.72 k | 45.78 k | 43.31 k | 67.48 k | 73.58 k | 77.14 k | 84.73 k | 91.12 k | 90.31 k | |

## Cost of Sales per Gram Sold | C$2 | C$1 | C$1 | C$1 | C$1 | C$1 | C$2 | C$2 | C$1 | C$1 | C$1 | |

## Production Cost per gram Sold | C$1 | C$1 | C$1 | C$1 | C$1 | C$1 | C$1 | C$1 | C$1 | C$0 | C$0 | |

## Cannabis Produced, kilograms | 1.16 k | 1.01 k | 1.20 k | 1.21 k | 2.21 k | 5 k | 7.82 k | 15.59 k | 29.03 k | 41.44 k | 30.69 k | |

## Cannabis Sold, kilogram and kilogram equivalents | 755 | 889 | 1.16 k | 1.35 k | 1.62 k | 2.68 k | 7 k | 9.16 k | 17.79 k | 12.46 k | 9.50 k | |

## Average Selling Price per Gram (Medical Cannabis) | C$9 | C$8 | C$7 | C$8 | C$8 | C$7 | ||||||

## Average Selling Price per Gram (Consumer Cannabis) | C$6 | C$5 | C$5 | C$5 | C$5 | C$4 | ||||||

## Average Selling Price per Gram (Wholesale Bulk Cannabis) | C$3 | C$3 | C$1 | |||||||||

## Manufacturing Facilities | 11 | 11 | 11 | 15 | 15 | |||||||

## Manufacturing Space, sq. ft | 4.61 m | 4.61 m | 4.61 m | 5.16 m | ||||||||

## Countries | 10 | 11 | 23 | 24 | 25 | 25 | ||||||

## Patent Applications | 101 | 108 | ||||||||||

## Annual Production Capacity (Aurora Eau), kilograms | 4.50 k | 4.50 k | 4.50 k | 4.50 k | 4.50 k | 4.50 k | ||||||

## Annual Production Capacity (Aurora Germany), kilograms | 2.10 k | 2.10 k | ||||||||||

## Annual Production Capacity (Aurora Mountain), kilograms | 4.80 k | 4.80 k | 4.80 k | 4.80 k | 4.80 k | 4.80 k | ||||||

## Annual Production Capacity (Aurora Nordic 1), kilograms | 8 k | 8 k | 8 k | 8 k | 8 k | 8 k | ||||||

## Annual Production Capacity (Aurora Nordic 2), kilograms | 120 k | 120 k | 120 k | 120 k | 120 k | 120 k | ||||||

## Annual Production Capacity (Aurora Portugal), kilograms | 4 k | 4 k | ||||||||||

## Annual Production Capacity (Aurora Prairie), kilograms | 19 k | 19 k | 19 k | |||||||||

## Annual Production Capacity (Aurora Ridge), kilograms | 7 k | 7 k | 7 k | |||||||||

## Annual Production Capacity (Aurora River), kilograms | 28 k | 28 k | 28 k | |||||||||

## Annual Production Capacity (Aurora Sky), kilograms | 100 k | 100 k | 100 k | 100 k | 100 k | 100 k | ||||||

## Annual Production Capacity (Aurora Sun), kilograms | 150 k | 150 k | 150 k | 230 k | 230 k | 230 k | ||||||

## Annual Production Capacity (Aurora Vie), kilograms | 4 k | 4 k | 4 k | 4 k | 4 k | 4 k | ||||||

## Annual Production Capacity (CanniMed), kilograms | 19 k | 19 k | 19 k | |||||||||

## Annual Production Capacity (ICC Labs), kilograms | 27.14 k | 27.14 k | 27.14 k | |||||||||

## Annual Production Capacity (MedReleaf Bradford), kilograms | 28 k | 28 k | 28 k | |||||||||

## Annual Production Capacity (MedReleaf Exeter), kilograms | 105 k | 105 k | 105 k | 105 k | ||||||||

## Annual Production Capacity (MedReleaf Markham), kilograms | 7 k | 7 k | 7 k | |||||||||

## Annual Production Capacity (Whistler Alpha Lake), kilograms | 500 | 500 | 500 | |||||||||

## Annual Production Capacity (Whistler Pemberton), kilograms | 5 k | 5 k | 5 k | |||||||||

## Average Selling Price per Gram | C$7 | C$8 | C$8 | C$7 | C$9 | C$6 | C$6 | |||||

## Brands | 9 | |||||||||||

## Patients (Canada) | 85 k |